paeciloquinones

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepaeciloquinones
Drug Alias Namepaeciloquinone Cpaeciloquinone Dpaeciloquinone Apaeciloquinone Fpaeciloquinone B +[6] 
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCiba Geigy Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A